Dementia Action Week: It’s time to talk about dementia

September 17, 2026

Dementia Action Week is held each September to raise awareness of dementia, reduce stigma and build greater understanding of the experiences of people living with dementia, their families and carers.

This year’s theme, ‘It’s time to talk about dementia’, encourages Australians to have more open conversations about dementia.

Dementia is Australia’s leading cause of death, with almost half a million Australians living with dementia and more than 1.7 million people involved in their care. Despite its significant impact across the community, dementia is still not talked about enough.

Starting conversations about dementia can help reduce stigma, encourage people to seek support earlier and improve access to diagnosis, treatment and care.

Dementia Australia provides a range of resources to help individuals, communities and health professionals start conversations about dementia, host or find Dementia Action Week events, and access information and support. Visit Dementia Australia to learn more.

Dementia support for health professionals

South Eastern Melbourne PHN provides a range of services, referral information and resources to support health professionals caring for people living with dementia.

Resources include:

Visit our dedicated dementia page for the complete range of dementia-related resources, services and information.

Education and resources

SEMPHN has collaborated with the South East Public Health Unit (SEPHU) to support dementia education and training for health professionals.

Recorded webinars include:

Health professionals can also access the new Staying Active with Dementia booklet, developed by the Monash Rehabilitation, Ageing and Independent Living (RAIL) Research Centre in partnership with the National Centre for Healthy Ageing (NCHA).

This practical, evidence-based resource supports people living with dementia, their families, carers and health professionals to understand the benefits of physical activity and how to incorporate it safely into everyday life. It includes information on:

  • why staying active matters
  • different types of physical activity that support health and wellbeing
  • getting started safely and confidently
  • maintaining motivation and overcoming barriers
  • accessing additional support and services.

Falls Prevention Community of Practice

SEPHU is also launching a Falls Prevention Community of Practice, bringing together healthcare professionals, community organisations, researchers, local government and service providers with an interest in falls prevention across south-east Melbourne.

Falls prevention is an important part of dementia care and healthy ageing. The Community of Practice will support ongoing collaboration, learning, networking and innovation across the region.

“Cognitive impairment can significantly increase a person's risk of falling, as cognitive function plays an important role in balance, mobility, and safe movement. Older adults living with dementia are two to three times more likely to experience a fall than those without cognitive impairment, with an estimated 60–80% experiencing a fall each year.”
Vignesh Lingam, Partnership Lead – Falls Prevention, South East Public Health Unit

If you are interested in joining, please contact Vignesh.Lingam@monashhealth.org.

Learn more about local dementia services and resources

Latest news

September 15, 2026
As warmer weather approaches, now is a timely opportunity to review your vaccine storage practices and complete your essential cold chain management audit.
September 13, 2026
South Eastern Melbourne PHN has launched the Clinical and Referral Guidance Hub (the Hub), a new platform providing primary care professionals in south east Melbourne with centralised access to local referral information and clinical guidance.
September 10, 2026
Sublocade® (long acting injectable buprenorphine) will be discontinued in Australia after 31 December 2026. The decision is not related to safety, quality or efficacy concerns and people currently receiving Sublocade® should continue their treatment as prescribed.